BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 32146128)

  • 1. Predictive factors for recurrence after complete metastasectomy in patients with metastatic renal cell carcinoma in the targeted therapy era.
    Takagi T; Fukuda H; Ishihara H; Yoshida K; Kondo T; Kobayashi H; Iizuka J; Okumi M; Ishida H; Omae K; Tanabe K
    Urol Oncol; 2020 May; 38(5):515-520. PubMed ID: 32146128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Significance of Metastasectomy in Patients with Metastatic Renal Cell Carcinoma in the Era of Targeted Therapy.
    Yu X; Wang B; Li X; Lin G; Zhang C; Yang Y; Fang D; Song Y; He Z; Zhou L
    Biomed Res Int; 2015; 2015():176373. PubMed ID: 26568955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of metastasectomy on prognosis in patients treated with targeted therapy for metastatic renal cell carcinoma.
    You D; Lee C; Jeong IG; Song C; Lee JL; Hong B; Hong JH; Ahn H; Kim CS
    J Cancer Res Clin Oncol; 2016 Nov; 142(11):2331-8. PubMed ID: 27553579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival and impact of clinical prognostic factors in surgically treated metastatic renal cell carcinoma.
    Tosco L; Van Poppel H; Frea B; Gregoraci G; Joniau S
    Eur Urol; 2013 Apr; 63(4):646-52. PubMed ID: 23041360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic impact of metastasectomy in renal cell carcinoma in the postcytokine therapy era.
    Ishihara H; Takagi T; Kondo T; Fukuda H; Tachibana H; Yoshida K; Iizuka J; Kobayashi H; Ishida H; Tanabe K
    Urol Oncol; 2021 Jan; 39(1):77.e17-77.e25. PubMed ID: 32863124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surgical treatment of atypical metastasis from renal cell carcinoma (RCC).
    Antonelli A; Arrighi N; Corti S; Legramanti S; Zanotelli T; Cozzoli A; Cunico SC; Simeone C
    BJU Int; 2012 Dec; 110(11 Pt B):E559-63. PubMed ID: 22639956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complete metastasectomy for renal cell carcinoma: Comparison of five solid organ sites.
    Jakubowski CD; Vertosick EA; Untch BR; Sjoberg D; Wei E; Palmer FL; Patel SG; Downey RJ; Strong VE; Russo P
    J Surg Oncol; 2016 Sep; 114(3):375-9. PubMed ID: 27338155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metastasectomy after targeted therapy in patients with advanced renal cell carcinoma.
    Karam JA; Rini BI; Varella L; Garcia JA; Dreicer R; Choueiri TK; Jonasch E; Matin SF; Campbell SC; Wood CG; Tannir NM
    J Urol; 2011 Feb; 185(2):439-44. PubMed ID: 21167518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes of complete metastasectomy in metastatic renal cell carcinoma patients: The Canadian Kidney Cancer information system experience.
    Dragomir A; Nazha S; Wood LA; Rendon RA; Finelli A; Hansen A; So AI; Kollmannsberger C; Basappa NS; Pouliot F; Soulières D; Heng DYC; Kapoor A; Tanguay S
    Urol Oncol; 2020 Oct; 38(10):799.e1-799.e10. PubMed ID: 32778475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk score and metastasectomy independently impact prognosis of patients with recurrent renal cell carcinoma.
    Eggener SE; Yossepowitch O; Kundu S; Motzer RJ; Russo P
    J Urol; 2008 Sep; 180(3):873-8; discussion 878. PubMed ID: 18635225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Impact of Local Intervention Combined with Targeted Therapy on Metastatic Renal Cell Carcinoma.
    Li JR; Ou YC; Yang CK; Wang SS; Chen CS; Ho HC; Cheng CL; Yang CR; Chen CC; Wang SC; Lin CY; Hung SC; Hsu CY; Chiu KY
    Anticancer Res; 2018 Sep; 38(9):5339-5345. PubMed ID: 30194186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Role of Metastasectomy in Patients with Renal Cell Carcinoma with Sarcomatoid Dedifferentiation: A Matched Controlled Analysis.
    Thomas AZ; Adibi M; Slack RS; Borregales LD; Merrill MM; Tamboli P; Sircar K; Jonasch E; Tannir NM; Matin SF; Wood CG; Karam JA
    J Urol; 2016 Sep; 196(3):678-84. PubMed ID: 27036304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of metastasectomy on overall survival in metastatic renal cell carcinoma: A systematic review and meta-analysis.
    Hsieh PY; Hung SC; Li JR; Wang SS; Yang CK; Chen CS; Lu K; Cheng CL; Chiu KY
    Urol Oncol; 2021 Jul; 39(7):422-430. PubMed ID: 33934963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series.
    Volpe A; Novara G; Antonelli A; Bertini R; Billia M; Carmignani G; Cunico SC; Longo N; Martignoni G; Minervini A; Mirone V; Simonato A; Terrone C; Zattoni F; Ficarra V; ;
    BJU Int; 2012 Jul; 110(1):76-83. PubMed ID: 22044519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematic Review of the Role of Cytoreductive Nephrectomy in the Targeted Therapy Era and Beyond: An Individualized Approach to Metastatic Renal Cell Carcinoma.
    Bhindi B; Abel EJ; Albiges L; Bensalah K; Boorjian SA; Daneshmand S; Karam JA; Mason RJ; Powles T; Bex A
    Eur Urol; 2019 Jan; 75(1):111-128. PubMed ID: 30467042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overall survival after immunotherapy, tyrosine kinase inhibitors and surgery in treatment of metastatic renal cell cancer: outcome of 143 consecutive patients from a single centre.
    De Lichtenberg TH; Hermann GG; Rørth M; Højer Larsen MJ; Mansourvar Z; Holm ML; Scheike T
    Scand J Urol; 2014 Aug; 48(4):379-86. PubMed ID: 24521185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complete Surgical Metastasectomy of Renal Cell Carcinoma in the Post-Cytokine Era.
    Lyon TD; Thompson RH; Shah PH; Lohse CM; Boorjian SA; Costello BA; Cheville JC; Leibovich BC
    J Urol; 2020 Feb; 203(2):275-282. PubMed ID: 31393812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgery for metastases of renal cell carcinoma: outcome of treatments and preliminary assessment of Leuven-Udine prognostic groups in the targeted therapy era.
    Tornberg SV; Visapää H; Kilpeläinen TP; Taari K; Järvinen R; Erkkilä K; Nisen H; Järvinen P
    Scand J Urol; 2018; 52(5-6):419-426. PubMed ID: 30663485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The survival benefit of metastasectomy for metastatic non-clear cell renal cell carcinoma: a retrospective cohort study.
    Dai J; He B; Zhang Y; Zhang H; Hu X; Xu L; Ni Y; Zhang X; Sun G; Zeng H; Shen P; Liu Z
    World J Urol; 2024 Apr; 42(1):259. PubMed ID: 38662226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulmonary metastasectomy from renal cell carcinoma including 3 cases with sarcomatoid component.
    Ueno T; Yamashita M; Sawada S; Sugimoto R; Nishijima N; Sugawara Y; Ninomiya I
    Gen Thorac Cardiovasc Surg; 2016 Mar; 64(3):149-52. PubMed ID: 26809845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.